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ABSTRACT
Cerium	oxide	nanoparticles	(CeO
2
	nanoparticles)	as	nanomaterials	have	promising	biomedical	applications.	
In	 this	 paper,	 the	 cytotoxicity	 induced	 by	 CONPs	 human	 cervical	 tumor	 cells	 was	 investigated. Cerium	 oxide	
nanoparticles	 were	 synthesized	 using	 the	 precipitation	 method.	 The	 nanoparticles	 were	 found	 to	 inhibit	 the	
proliferation	of	HeLa	human	cervical	tumor	cells	in	a	dose	dependent	manner	but	did	not	showed	to	be	cytotoxic	
as	analyzed	by	MTT	assay.	The	administrated	treatment	decreased	the	HeLa	cell	viability	cells	from	100%	to	65%	
at	the	dose	of	100	μg/mL.	 
Keywords: nanoparticles, cerium, cervical cancer, MTT.
INTRODUCTION
In	 the	 last	 decades,	 nanotechnology	 as	 tool	
used	for	preventive	or	alternative	for	degenerative	
diseases	 is	 becoming	 an	 important	 area	 of	
biomedical	research	(Salata	2004;	Sahoo,	Parveen	
et	 al.	 2007).	 Different	 nanoparticles	 having	 size	
range	from	10-200	nm	were	used	as	drug	delivery	
systems,	 fluorescents	 biomarkers,	 protein	
detectors	 or	 tissue	 engineering	 (Mahtab,	 Rogers	
et	 al.	 1995);	 Wang,	 Mamedova	 et	 al.	 (2002);	
(Pantarotto,	 Partidos et al.	 2003).	 In	 particular,	
CeO
2
	 nanoparticles	 have	 shown	 a	 multiples	
applications	 in	 biomedical	 studies	 (Celardo,	
Pedersen	 et	 al.	 2011;	 Celardo,	 Traversa	 et	 al.	
2011).	The	interest	for	CeO
2
	nanoparticles	ability	
against	 oxygen	 reactive	 species	 comes	 from	 its	
oxidants’	states	3+	vs.	4+	and	been	evaluated	using	
specific	 markers	 such	 as	 antioxidant	 enzymes	
(Korsvik,	 Patil	 et	 al.	 2007;	 Karakoti,	 Singh	 et	 al.	
2009;	Pirmohamed,	Dowding	et	al.	2010).	Due	to	
their	 antioxidant	 proprieties	 CeO
2
 nanoparticles 
exhibit	 anti-inflammatory,	 antiproliferative	 and	
protective	potential	 against	 cancer	or	neurologic	
diseases	 (Schubert,	 Dargusch	 et	 al.	 2006;	 Hirst,	
Karakoti	et	al.	2009;	Alili,	Sack	et	al.	2013;	Ciofani,	
Genchi	 et	 al.	 2013;	 Wason	 and	 Zhao	 2013).	
There	 are	 studies	 that	 report	 the	 synthesis	 of	
ceria	 ultra-small	 NPs	 by	 the	 precipitation	 using	
different	 organic	 stabilizers	 (Chen	 and	 Chang	
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2005;	 Ivanova,	 Shekunova	 et	 al.	 2011;	 Babenko,	
Zholobak	et	al.	2012).	 In	a	recent	study	(G.	Renu	
at al.	 2012)	 it	was	evaluate	 the	 selective	 toxicity	
of	 CeO2	 nanoparticles	 towards	 the	 normal	 and	
the	 cancer	 cell	 lines.	 they	 results	 showed	 that	
nanoparticles	were	found	to	be	nontoxic	towards	
normal	 cell	 lines	 (L929)	 but	 cytotoxic	 towards	
prostate	 cancer	 cell	 lines	 (PC-3)	 as	 analyzed	 by	
MTT	 assay	 (Renu	 2012).	 Another	 study,	 report	
a	 significant	 cytotoxicity	 and	 morphological	
changes	 in	 lung	 adenocarcinoma	 (A549)	 cells	
caused	 by	 the	 CeO
2
 nanoparticles treatment. 
Their	 study	 demonstrated	 that	 ROS	 mediated	
DNA	damage	and	cell	cycle	arrest	is	an	important	
key	in	CeO
2
 nanaoparticles induced apoptotic cell 
death	 in	 A549	 cells	 (Mittal	 and	 Pandey	 2014).	
Moreover,	 CeO
2
 nanoparticles treatment has 
been	 shown	 to	 prevent	 macular	 degeneration	
and	 also	 the	 progression	 of	 diabetes	 (Kong,	 Cai	
et	al.	2011;	Pourkhalili,	Hosseini	et	al.	2011;	Roy,	
Dontamalla	 et	 al.	 2011;	 Pourkhalili,	 Hosseini	 et	
al.	2012).	Based	on	previously	studies	which	have	
demonstrated	 that	 CeO
2	
nanoparticles	 may	 have	
a	possible	potential	as	a	therapeutic	agent	for	the	
treatment	of	cancer,	we	develop	a	complementary	
experiment	 witch	 included	 the	 synthesis	 and	
characterization	 of	 CeO
2	
nanoparticles and 
evaluation	 of	 antiproliferative	 potential	 on	 HeLa	human cervical tumor cells. 
MATERIALS AND METHODS
Materials 
Nitrate	 cerium,	 ammonium,	 MTT	 3-[4,	
5-dimethylthiazol-2-yl	 -2,	5-diphenyl	 tetrazolium	
bromide	 reagent,	 phosphate-buffered	 saline	
(PBS),	 DMSO	 (dimethil	 sulphoxide),	 Dulbecco’s	
Modified	 Eagle’s	 medium	 (DMEM),	 and	 fetal	
bovine	serum	(FBS),	were	purchased	from	Sigma-
Aldrich	(Darmstadt,	Germany).	All	other	solvents	
were	analytical	or	reagent	grade.
Synthesis of cerium oxide nanoparticles
For	the	synthesis	of	the	CeO2	nanoparticles	it	
was	used	the	precipitation	method	applied	directly	
into	a	solution	of	Ce	(OH)
	4
 at room temperature 
followed	 by	 the	 dehydration	 of	 the	 unstable	
cerium	 (IV)	 hydroxide.	 In	 this	 report	 the	 CeO2	
nanoparticles	 were	 prepared	 via	 a	 precipitation	
approach	by	modifying	a	experimental	procedure	
used	 by	 Ivanova	 et	 al	 (Ivanova,	 Shekunova	 et al. 
2011).	 The	 synthesis	 of	 CeO2	 nanoparticles	was	
obtained	 by	 mixing,	 under	 magnetic	 stirring,	
an	 aqueous	 solution	 formed	 by	mixing	 a	 0.05	M	
cerium	nitrate	 solution,	 Ce(NO
3
)
3
	 and	 citric	 acid,	
C
6
H
8
O
7
	as	stabilizer	agent	with	the	corresponding	
stoichiometric	3	M	ammonia	 solution,	NH
4
OH	as	
precipitating	 reagent.	 The	 final	 concentration	 of	
CeO
2
	was	estimated	at	50	mM.
Characterization of cerium oxide 
nanoparticles
The	 morphology	 of	 the	 CeO
2
 nanoparticles 
was	 determinated	 by	 transmission	 electron	
microscopy	 (TEM),	 using	 a	 JEOL	 JEM1010	
transmission	electron	microscope	operating	at	an	
accelerating	 voltage	 of	 100	 kV,	 equipped	 with	 a	
MegaViewIII	CCD	camera.	For	the	measurements,	
10	µl	nanoparticles	in	solution	was	placed	onto	a	
copper	grid	and	allowed	to	dry.	The	identification	
of	 CeO	 bonds	 was	 made	 by	 Fourier	 transform	
infrared	(FTIR)	using	 IR	Prestige	21	FTIR	8400S	
(Shimazu)	 spectrometer	 with	 a	 single	 reflection	
horizontal	 ATR	 accessory. The	 absorption	 FT-IR	
spectrum	of	the	CeO
2
	nanoparticles	was	registered	
between	700	and	2000	cm-1	was	collected	at	room	temperature.
Cell and cell culture 
Human	 tumor	 cervical	 HeLa	 was	 kindly	
provided	 by	 The	 Oncology	 Institute	 “Prof.	 Dr.	
Ion	 Chiricuță”	 Cluj-Napoca.	 The	 cell	 line	 was	
maintained	 in	 Dulbecco’s	 modified	 Eagle’s	
medium	 containing	 1	 g/L	 glucose	 supplemented	
with	 10%	 fetal	 bovine	 serum,	 1	 mM	 glutamine,	
1%	gentamicin,	and	1%	nonessential	amino	acids	
at	 37°C	 in	 an	 atmosphere	 of	 5%	 CO2	 and	 95%	
relative	humidity.	
Analysis of cell proliferation (MTT assay)
In	order	to	evaluate	the	cell	viability,	HeLa	cells	
were	cultured	plated	(8000	cells	per	well)	 in	96-
well	plates	for	24	h.	The	culture	medium	was	then	
replaced	with	complete	medium	containing	0–100	
g/mL	CeO2	nanoparticles.	The	number	of	viable	cells	
was	determined	with	 the	3-(4,5-dimethylthiazol-
2-yl)-	 2,5-diphenyltetrazolium	 bromide	 cell	
proliferation	 reagent.	 Three	 phosphate-buffered	
saline	 washing	 steps	 were	 followed	 by	 1	 h	 of	
incubation	 with	 3-(4,5-dimethylthiazol-	 2-yl)-
2,5-diphenyltetrazolium	 bromide	 solution	 (0.5	
mg/mL)	 in	 Dulbecco’s	 modified	 Eagle’s	 medium	
without	 phenol	 red.	 The	 formazan	 particles	
were	 solubilized	 with	 dimethyl	 sulfoxide.	 The	
absorbance	 was	 read	 at	 550	 nm	 and	 expressed	
relative	 at	 that	 630	 nm	 (for	 background)	 with	
the	 HT	 Synergy	microplate	 plate	 reader	 (BioTek	
111
 Bulletin UASVM Food Science and Technology 72(1) / 2015
Evaluation	of	Antiproliferative	Potential	of	Cerium	Oxide	Nanoparticles	on	HeLa	Human	Cervical	Tumor	Cell
Instruments,	USA.	The	results	were	expressed	as	
survival	percentage	with	respect	 to	an	untreated	control.
RESULTS AND DISCUSSIONS
Characterization of cerium oxide 
nanoparticles by TEM
 This	 study	 utilizes	 a	 precipitation	
method	as	an	approach	for	the	synthesis	of	CeO
2	
nanoparticles.	 Fig.	 1	 shows	 the	 transmission	
electron	 micrographs	 of	 the	 obtained	 CeO
2
 
nanoparticles.	 It	 can	 be	 observed	 that	 the	
particles	are	poly	dispersed	and	relatively	equal	in	dimension. 
Characterization of cerium oxide 
nanoparticles by FTIR 
The	Fourier	Transform	Infrared	Spectroscopy	
(FTIR)	 measurement	 of	 the	 obtained	 CeO
2
 
nanoparticles	 is	 presented	 in	 Fig.	 2.	 It	 reveals	 a	
group	of	strong	intense	bands	at	830,	1320,	1555	
and	 around	 3000	 cm-1.	 Low	 intensity	 groups	
are	 observed	 at	 1045	 and	 2360	 cm-1.	 The	 NO
3
 
specific	vibrations	at	1320	cm−1	are	attributed	to	
traces	 of	 Ce(NO3)3·6H2O	used	 as	 reagent	 in	 the	
synthesis	(Albadarin,	Yang	et	al.	2014).	The	band	
at	 approximately	 830	 cm−1 is similar to those 
reported	 in	 the	 literature	 (Albadarin,	 Yang	 et	 al.	
2014;	Thakur	and	Patil	 2014).	The	O-H	and	N-H	
deformation	(scissoring)	modes	occur	at	1625	cm-
1.	The	very	weak	band	at	1030	cm-1	is	due	to	the	
O-H	and	N-H	wagging	modes.	Also,	one	can	observe	
the	characteristic	vibration	bands	of	NO3-	group:	
the	stretching	vibration	bands	in	the	region	1515-
1480	 cm-1	 and	 1350-	 1280	 cm-1.	 The	 obtained	
IR	spectrum	of	analyzed	nanoparticles	presents	a	
high	intensity	band	at	lower	wavenumbers,	below	
630	cm-1,	which	is	attributed	to	the	cerium-oxygen	
vibration	ν	(Ce-O)	(Khan	and	Ahmad	2013).
A. B.
Fig.1.	TEM	micrograph	recorded	of	CeO
2
	nanoparticles	(A-100nm,	B-200nm)
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Fig. 2.	FTIR	spectra	recorded	from	CeO
2	
nanoparticles Fig. 3.	Results	of	MTT	proliferation	assay	of	human	cervical	cancer	HeLa-treated	cells	by	different	concentration	of	CeO2	nanoparticles	(0-100ug/ml)
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Inhibition of tumor cell proliferation
The	 administrated	 CeO
2
	 nanoparticles	 treat-
ment	 inhibited	 the	 proliferation	 of	 HeLa	 cells	 in	
a	dose	dependent	manner	but	did	not	showed	to	
be	cytotoxic.	The	influence	of	CeO2	nanoparticles	
on	cell	proliferation	was	evaluated	by	measuring	
the	 mitochondrial	 succinate	 dehydrogenase	
activity	 in	 HeLa-treated	 cells	 incubated	 for	 24h.	
The	 administrated	 treatment	 decreased	 the	
HeLa	cell	viability	cells	from	100%	to	65%	at	the	
dose	of	100	μg/mL	 (Fig.	 3).	Those	 results	 are	 in	
agreement	with	 a	 recent	 study	were	 cytotoxicity	
tests	showed	no	toxicity	after	Caco-2	cell	exposure	
to	 these	 various	 CeO2	 nanoparticles	 up	 to	 170	
μg/mL	(Fisichella,	Berenguer	et	al.	2014).	Similar	
results	were	obtained	in	a	recent	study	on	HT-1080	
human	breast	fibrosarcoma	cell	line	were	cerium	
oxide	 nanoparticles	 showed	 to	 reduce	 oxidant-
mediated	apoptosis	in	target	cells	as	judged	by	the	
activation	of	caspase	3	(Clark,	Zhu	et	al.	2011).
In	another	published	study,	the	cerium	oxide	
nanoparticles	were	found	to	be	nontoxic	towards	
normal	 cell	 lines	 (L929)	 but	 cytotoxic	 towards	
prostate	 cancer	 cell	 lines	 (PC-3)	 (Renu	 2012).	
Also	 the	morphology	of	 the	 cells	determinate	by	
phase	contrast	microscopy	is	affected	and	can	be	
observed	in	Fig.	4.
Characteristic	morphological	changes	such	as	
cell	detachment,	rounding	up	and	shrinkage	were	
observed	 by	 contrast-phase	microscopy	 after	 24	
h	of	 exposure	 to	different	 concentration	of	CeO2	
nanoparticles	 (0-100ug/ml)	 in	 Hela	 cells.	 The	
decrease	in	observed	cell	proliferation	of	B16-F10	
was	 in	 good	 correlation	 with	 time	 and	 dose	dependent manner.
DIACONEASA	et al.
Control 50	μl/ml
75	μg/ml 100μg/ml
Fig. 4.	Comparative	morphology	of	HeLa	cells	non-treated	and	treated	with	CeO2	nanoparticles
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CONCLUSION
CeO2	nanoparticles	prepared	by	precipitation	
method	showed	to	be	poly	dispersed	and	relatively	
equal	as	size	range	by	TEM	analysis.	
Present	 study	 showed	 that	 CeO2	 nanoparti-
cles	 cause	 morphological	 changes	 and	 have	antiproliferative potential in a concentration 
and	 time	 dependent	 manner.	 These	 results	 are	
confirmed	 by	 phase	 contrast	 microscopy.	 Along	
with	 this,	 the	 cytotoxicity	 CeO2	 nanoparticle	 is	
a	promising	 result	which	makes	cerium	oxide	as	
a	 possible	 delivery	 system	 for	 human	 cervical	cancer cells.
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